Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Molecular Medicine (Cambridge, Mass.)|February 29, 2012
Dichotomy in Hedgehog signaling between human healthy vessel and atherosclerotic plaquesKarla C S Queiroz, Maarten F Bijlsma, René A Tio, et al.
Molecular Oncology|April 23, 2024
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenuesAndrea Vallés-Martí, Richard R de Goeij-de Haas, Alex A Henneman, et al.
Scientific Reports|June 11, 2017
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysisA Creemers, E Ter Veer, L de Waal, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatmentTessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, et al.
Nature Immunology|July 19, 2005
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathwayWouter J de Jonge, Esmerij P van der Zanden, Frans O The, et al.
Translational Oncology|August 16, 2024
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker studyCharlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, et al.
Cell Reports|June 3, 2023
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinomaAndrea Vallés-Martí, Giulia Mantini, Paul Manoukian, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|June 17, 2020
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor typesTom van den Ende, Héctor G van den Boorn, Nadine M Hoonhout, et al.
JCI Insight|July 8, 2020
Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targetsTessa Ys Le Large, Giulia Mantini, Laura L Meijer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 8, 2015
Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancerRemy Klaassen, Roelof J Bennink, Geertjan van Tienhoven, et al.
Pageof 17